Vascular Architects: Going Against the Peripheral Flow
Executive Summary
With most peripheral device companies focusing on interventionalists, Vascular Architects is changing course to make the forgotten vascular surgeon their primary customer.
You may also be interested in...
Venture Debt: Device Financing Lifeline or Anchor?
Venture debt has become an increasingly popular financing option particularly among device companies. But, if not used properly, it can help sink rather than save a start-up.
Venture Debt: Device Financing Lifeline or Anchor?
Venture debt has become an increasingly popular financing option particularly among device companies. But, if not used properly, it can help sink rather than save a start-up.
Venture Debt: Device Financing Lifeline or Anchor?
Venture debt has become an increasingly popular financing option particularly among device companies. But, if not used properly, it can help sink rather than save a start-up.